Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis

Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis

In the present study, the objective was to attain a localized lung delivery of an anti-tubercular fluoroquinolone, moxifloxacin (MXF), targeting the alveolar macrophages through a non-invasive pulmonary route using inhalable microspheres as a dry powder inhaler approach. MXF-loaded poly (lactic-co-g...

Full description

Bibliographic Details
Main Authors: Bhavya Vishwa, Afrasim Moin, D. V. Gowda, Syed M. D. Rizvi, Wael A. H. Hegazy, Amr S. Abu Lila, El-Sayed Khafagy, Ahmed N. Allam
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Pharmaceutics
Subjects:
tuberculosis
microspheres
moxifloxacin
dry powder inhalers
pulmonary drug delivery
Online Access:https://www.mdpi.com/1999-4923/13/1/79

Internet

https://www.mdpi.com/1999-4923/13/1/79

Similar Items